Hailong Wang

Title: Hailong Wang: Innovator in Pharmaceutical Processes

Introduction

Hailong Wang is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of prasugrel, a medication used to prevent blood clots. His innovative approach has led to advancements in both the efficiency and safety of drug production.

Latest Patents

Hailong Wang holds a patent for a process for the preparation of prasugrel and several novel crystalline forms of prasugrel hydrochloride. This patent discloses a method that utilizes solvents with low boiling points and low toxicity, avoiding the use of harmful solvents like toluene and acetonitrile. The process not only enhances the yield of prasugrel to over 85% but also ensures a purity level exceeding 99.5%. The novel crystalline forms, designated as H1, H2, and H3, exhibit excellent oral absorbability and low toxicity, making them suitable for treating diseases related to thrombosis or embolism.

Career Highlights

Throughout his career, Hailong Wang has worked with prominent pharmaceutical companies, including Sunshine Lake Pharma Co., Ltd. and Yichang Changjiang Pharmaceutical Co., Ltd. His expertise in pharmaceutical processes has been instrumental in developing safer and more effective medications.

Collaborations

Hailong Wang has collaborated with several professionals in the field, including Lijun Li and Zhongqing Wang. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Hailong Wang's innovative work in the preparation of prasugrel showcases his commitment to improving pharmaceutical processes. His contributions have the potential to significantly impact the treatment of thrombotic diseases, highlighting the importance of innovation in the medical field.